Interferon gamma-1b: CNCT completed enrollment in its Phase III trial

Connetics Corp. (formerly Connective Therapeutics Inc., CNCT), Palo

Read the full 84 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE